Industry to discuss various critical issues during pharma event

Image
Press Trust of India New Delhi
Last Updated : Dec 20 2018 | 8:35 PM IST

The pharmaceutical industry would deliberate on various issues related to generic drugs and medical devices at 70th edition of Indian Pharmaceutical Congress (IPC) at Amity University, Noida, from December 21-23.

The event will see 125 speakers and organisers expect around 6,000 delegates this year from all the sections of the pharma fraternity from India as well as abroad.

"For the past 70 years, the meeting of minds at each edition of IPC has played a significant role in what we have achieved today," Organising Secretary of local organising committe of the event Atul Nasa told reporters here.

The discourses at the event will not only bring broad consensus across industry but also will help the industry map the way ahead, he added.

He added that over the three days industry stakeholders would deliberate upon important topics retaled to APIs, generic formulations, diagnostics and medical devices and biosimilars.

Other key issues that would be discussed include the need for adequate regulatory framework to support investment on innovative products and expedite pre-clinical research launch of new drugs, the orgnisers said.

The event will be inaugurated by Vice President M Venkaiah Naidu.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 20 2018 | 8:35 PM IST

Next Story